Individual serological follow-up of patients with suspected or confirmed abdominal angiostrongyliasis
AUTOR(ES)
Palominos, Penélope E, Gasnier, Rose, Rodriguez, Rubens, Agostini, Aventino A, Graeff-Teixeira, Carlos
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
31/01/2008
RESUMO
Abdominal angiostrongyliasis (AA) is a zoonotic nematode infection caused by Angiostrongylus costaricensis, with widespread occurrence in the Americas. Although the human infection may be highly prevalent, morbidity is low in Southern Brazil. Confirmed diagnosis is based on finding parasitic structures in pathological examination of biopsies or surgical resections. Serology stands as an important diagnostic tool in the less severe courses of the infection. Our objective is to describe the follow up of humoral reactivity every 2-4 weeks up to one year, in six individuals with confirmed (C) and ten suspected (S) AA. Antibody (IgG) detection was performed by ELISA and resulted in gradually declining curves of reactivity in nine subjects (56%) (4C + 5S), that were consistently negative in only three of them (2C + 1S) after 221, 121 and 298 days. Three individuals (2C + 1S) presented with low persistent reacitivity, other two (1C + 1S) were serologically negative from the beginning, but also presenting a declining tendency. The study shows indications that abdominal angiostrongyliasis is usually not a persistent infection: although serological negativation may take many months, IgG reactivity is usually declining along time and serum samples pairing may add valuable information to the diagnostic workout.
Documentos Relacionados
- Follow-up of patients with suspected multiple sclerosis: a clinical and electrophysiological study.
- Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis.
- Clinical and Serological Follow-Up of Patients with Human Granulocytic Ehrlichiosis in Slovenia
- Serological follow-up of patients involved in a localized outbreak of leptospirosis.
- Follow-up of patients with colorectal cancer. A meta-analysis.